Physical and Engineering Sciences in Oncology

by: Michael Saunders

The National Science Foundation, otherwise referred to as NSF, is a United States Government agency that is primarily responsible for pursuing and ensuring fundamental research studies and education in all the non-medical fields of science and engineering.

The programs and activities of the NSF are administered in an effort to help them realize their mission, which is "to promote the progress of science; to advance the national health, prosperity, and welfare; to secure the national defense."

In keeping with this mission, the National Science Foundation, in close cooperation the National Cancer Institute, has recently developed the Physical and Engineering Sciences in Oncology Program wherein they intend to obtain a more thorough understanding of cancer disorders with the application of physical and engineering sciences.

The folks at NSF believe that the discovery of significant advances is greatly possible as a result of the consistent investments in inter- and multi-disciplinary research studies concerning the application of physical/engineering and life sciences and its impact on unraveling the cause and origin of cancer cell formation.

In addition, the NSF perceives that these advances will significantly contribute to the prevention, early detection, and efficient treatment of cancer disorders. Which is very much essential because cancer is one of the most fatal diseases in the world today.

The proposals that will be submitted to the NSF should include the following:

  (continued...)

Physical and Engineering Sciences in Oncology
  Page 2

About The Author Michael Saunders is an editor of TopGovernmentGrants.com one the the most comprehensive Websites offering information on government grants and federal government programs. He also maintains Websites providing resources on community grants and health grants.

Additional Resources

category - Health Grants

Early-Stage Innovative Technology Development for Cancer Research Program
The National Institutes of Health has collaborated with the National Cancer Institute(NCI) in order to establish Early-Stage Innovative Technology Development for Cancer Research Program, wherein both agencies intend to solicit grant applications expressing intents to conduct funded exploratory research projects that concentrate on the inception and development unique, innovative technological advances that could potentially be utilized in the study of cancer.

---

Pilot Surveillance System for High Impact/Low Prevalence Congenital and Inherited Conditions Program
The Centers for Disease Control and Prevention has recently established the Pilot Surveillance System for High Impact/Low Prevalence Congenital and Inherited Conditions Program wherein it seeks to create and evaluate a surveillance system for congenital and inherited disease conditions.

---

Development of Therapeutics and Diagnostics for Biodefense Program
The National Institutes of Health, in partnership with the National Institute of Allergy and Infectious Diseases(NIAID), has established the Development of Therapeutics and Diagnostics for Biodefense Program in an attempt to seek research proposals that desire to support the development of lead candidate diagnostics or therapeutics against NIAID Category A, B, or C priority agents.

---

Critical Congenital Heart Disease Newborn Screening Demonstration Program
The Health Resources and Services Administration has recently constituted the Critical Congenital Heart Disease (CCHD) Newborn Screening Demonstration Program in order to support and encourage the development, dissemination, and validation of screening protocols and newborn screening infrastructure for point of care screenings that are specific to Critical Congenital Heart Diseases.

---